Integrating AI with flow cytometry revolutionizes drug discovery and oncology, offering precise cell analysis and real-time ...

To support physicians in treating cancer patients, oncology laboratories can benefit from adopting end-to-end automation of flow cytometry workflows. Rapid advances in automation are improving ...

The following is a summary of “Elevated Fcy receptor expression augments pro-inflammatory macrophage phagocytosis in systemic ...

The following is a summary of “Impact of liquid–liquid phase separation- and immune-related gene signatures on multiple ...

Researchers have uncovered a hierarchical structure of immune-privileged stem cells in bone marrow niches, revealing their ...

As market values increase for computational biology and data science, biopharma companies are looking to hire R&D ...

This important work substantially advances our understanding of reactive oxygen species (ROS) as a regenerative signal during postnatal cerebellum repair by activating adaptive progenitor ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

Cladribine is under development for the treatment of neurological diseases including neuromyelitis optica and neuromyelitis optica spectrum disorder, myasthenia gravis (MG). It is administered through ...

Enpatoran is under clinical development by Merck and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia.

Specialist blood transplant and transfusion practice could be improved by a breakthrough made by University of Oxford scientists.

By inhibiting the DNA polymerases, BKC enhances the endogenous RS in cancer cells, leading to increased DNA damage. IBC specifically inhibits CHK2 to prevent DNA repair. The combined use of BKC and ...